The Neoantigen Summit is the dedicated end-to-end industry focused meeting ensuring the supercharging of immunotherapies and cancer vaccines to bring truly individualized therapies to patients in need.
Hear the latest clinical updates from pioneers in this field and define your commercialization roadmap to achieve future regulatory success, scale manufacturing and ensure enhanced clinical efficacy.
In such a rapidly evolving field, this is the premier platform to benchmark against the industry and network with the crème de la crème of neoantigen therapy developers.
Join us as the industry seeks to demonstrate significant clinical proof of concept and ensure you and the key stakeholders can make the scientific, clinical and commercial decisions needed to bring these therapies market.